Work

Abstract 398: NOVO-111: A macrocycle drug conjugate engineered for improved tumor targeting and tolerability.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-398

Authors: Jonathan Felipe Aramubla, Guangan He, Gregory Thiabaud, Kathryn Shelton, Luke J. Segura, Jonathan L. Sessler, Rick A. Finch, Zahid H. Siddik

Institutions: The University of Texas MD Anderson Cancer Center, The University of Texas at Austin, Texas Biomedical Research Institute

Language: English

Topic: Metal complexes synthesis and properties

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148727687

Cites:

Cited by:

Related to: